Online citations, reference lists, and bibliographies.
← Back to Search

Aqueous Core Nanocapsules: A New Solution For Encapsulating Doxorubicin Hydrochloride

S. Vrignaud, N. Anton, C. Passirani, J. Benoît, P. Saulnier
Published 2013 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In this study, we propose a new solution for the nanoencapsulation of hydrophilic anticancer drug, doxorubicin hydrochloride (DOX). The drug molecules are solubilized in the core of aqueous nanoreservoirs, so-called aqueous core nanocapsules (ACN) recently developed by our team, and dispersed in aqueous bulk media. Since it is well acknowledged that the nanoencapsulation of DOX has many advantages, like reducing the sides effects (e.g. cardiac toxicity), we propose through the present study a novel formulation solution for this purpose. After focusing on the formulation process for optimizing the drug encapsulation yield, the DOX-release profiles were followed up and analyzed. Different physicochemical and in vitro characterization were performed, and complement activation experiments. ACN were shown efficient to encapsulate DOX reaching yields as high as 80%, followed by a sustained release governed by a diffusion-controlled mechanism. The loaded nanocarriers showed low levels of complement activation, compatible with stealth properties. To summarize, this study brings out a new tool for the nanoencapsulation of hydrophilic anticancers and could open new doors for the administration of this particular class of drugs.
This paper references
10.1016/j.nano.2010.01.012
In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery.
M. Rahimi (2010)
Consumption of CH50 units as a function of nanoparticle surface area
10.1016/j.jconrel.2008.02.007
Design and production of nanoparticles formulated from nano-emulsion templates-a review.
N. Anton (2008)
10.1023/A:1007582332491
Polyisobutylcyanoacrylate Nanocapsules Containing an Aqueous Core as a Novel Colloidal Carrier for the Delivery of Oligonucleotides
G. Lambert (2004)
10.1016/S0142-9612(99)00125-8
Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles.
C. E. Soma (2000)
10.1016/J.EJPS.2006.06.003
Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles.
D. Missirlis (2006)
10.1002/mabi.200800293
Fluorescent polyurethane nanocapsules prepared via inverse miniemulsion: surface functionalization for use as biocarriers.
Umaporn Paiphansiri (2009)
10.1615/CRITREVTHERDRUGCARRIERSYST.V19.I2.10
Nanocapsule technology: a review.
P. Couvreur (2002)
10.1007/s11095-006-0282-x
A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells
H. L. Wong (2006)
10.1016/J.IJPHARM.2006.10.031
Encapsulation of mono- and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers.
H. Hillaireau (2007)
10.1007/s11095-006-9061-y
Pegylated Nanocapsules Produced by an Organic Solvent-Free Method: Evaluation of their Stealth Properties
A. Béduneau (2006)
10.1016/J.IJPHARM.2006.07.006
Encapsulation of antiviral nucleotide analogues azidothymidine-triphosphate and cidofovir in poly(iso-butylcyanoacrylate) nanocapsules.
H. Hillaireau (2006)
Mdicaments antitumoraux et perspectives dans le traitement des cancers
10.1021/la901565q
Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules.
N. Anton (2009)
10.5555/URI:PII:009377549290207H
The cardiotoxicity of chemotherapeutic drugs.
A. Allen (1992)
10.1016/j.ejpb.2011.02.015
Reverse micelle-loaded lipid nanocarriers: a novel drug delivery system for the sustained release of doxorubicin hydrochloride.
S. Vrignaud (2011)
10.1021/bm901414k
Cross-linked starch capsules containing dsDNA prepared in inverse miniemulsion as "nanoreactors" for polymerase chain reaction.
Grit Baier (2010)
10.1002/MACP.200700254
Nanocapsules synthesized by miniemulsion technique for application as new contrast agent materials
Nicole Jagielski (2007)
10.1016/j.addr.2012.09.028
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC).
J. Siepmann (2001)
10.1016/j.ijpharm.2011.10.004
Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agents.
Y. Liu (2011)
10.1016/S0168-3659(01)00294-2
Chitosan nanoparticles as delivery systems for doxorubicin.
K. Janes (2001)
10.1016/j.biomaterials.2011.10.064
Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin.
H. Cho (2012)
10.1007/S00396-005-1438-7
Preparation and characterization of self-assembled nanoparticles based on glycol chitosan bearing adriamycin
J. Park (2006)
10.1006/PHRS.2000.0695
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats.
A. Fundaró (2000)
10.1016/j.biomaterials.2011.07.057
Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles.
S. Vrignaud (2011)
10.1016/J.IJPHARM.2004.01.031
Hemolysate-filled polyethyleneimine and polyurea microcapsules as potential red blood cell substitutes: effect of aqueous monomer type on properties of the prepared microcapsules.
I. El-Gibaly (2004)
10.1021/la9017097
Surface-active monomer as a stabilizer for polyurea nanocapsules synthesized via interfacial polyaddition in inverse miniemulsion.
Eva-Maria Rosenbauer (2009)
Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation
A. Rahman (2007)
10.1021/MA0621932
Polymeric Nanoreactors for Hydrophilic Reagents Synthesized by Interfacial Polycondensation on Miniemulsion Droplets
D. Crespy (2007)
10.1002/JBM.A.30711
Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake.
A. Vonarbourg (2006)



This paper is referenced by
10.1016/j.jconrel.2020.03.042
Lipid nanocapsules to enhance drug bioavailability to the central nervous system.
R. P. Moura (2020)
10.1016/j.actbio.2017.03.054
Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Min Sil Kang (2017)
10.3109/03639045.2013.788012
Bacteriolysis by vancomycin-conjugated acryl nanoparticles and morphological component analysis
N. Shimizu (2014)
Comparison of topical quercetin nanoformulations for skin protection
T. Hatahet (2016)
10.1039/C9TB00587K
Oily core/amphiphilic polymer shell nanocapsules change the intracellular fate of doxorubicin in breast cancer cells.
J. Coelho (2019)
10.1016/j.ijpharm.2016.12.043
Dermal quercetin lipid nanocapsules: Influence of the formulation on antioxidant activity and cellular protection against hydrogen peroxide.
T. Hatahet (2017)
10.1016/J.CEJ.2015.04.152
Doxorubicin-loaded magnetic nanocapsules based on N-palmitoyl chitosan and magnetite: Synthesis and characterization
V. Balan (2015)
Développement de deux plateformes pharmaceutiques gélifiées : un hydrogel de nanocapsules lipidiques et un organogel avec le même agent de réticulation
M. Pitorre (2017)
10.1039/c8cs00099a
Nanoencapsulation of phase change materials for advanced thermal energy storage systems
E. Shchukina (2018)
10.22377/AJP.V13I04.3404
Aqueous-Core Nanocapsules of Lamivudine: Optimization by Design of Experiments
G. Srikar (2019)
10.1016/j.ijpharm.2013.12.050
Encapsulation and controlled release of hydrophilic pesticide in shell cross-linked nanocapsules containing aqueous core.
Chuxiang Sun (2014)
10.1016/S1773-2247(13)50084-0
Lipid Nanocapsules: A Nanocarrier Suitable for Scale-Up Process
O. Thomas (2013)
10.3390/nano10050847
Polymeric Nanocapsules as Nanotechnological Alternative for Drug Delivery System: Current Status, Challenges and Opportunities.
S. Deng (2020)
10.1016/j.cis.2019.04.010
Emulsion and miniemulsion techniques in preparation of polymer nanoparticles with versatile characteristics.
Ali Gharieh (2019)
10.1039/C3SM51064F
Adhesive water-in-oil nano-emulsions generated by the phase inversion temperature method
N. Anton (2013)
10.1590/S2175-97902019000118736
Study on influence of polymer and surfactant on in vitro performance of biodegradable aqueous-core nanocapsules of tenofovirdisoproxil fumarate by response surface methodology
G. Srikar (2019)
10.1039/C6TA06189C
Nanocapsules containing salt hydrate phase change materials for thermal energy storage
M. Graham (2016)
10.1016/j.colsurfb.2017.04.016
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands.
C. Carbone (2017)
10.1016/j.colsurfb.2016.02.002
Innovative hybrid vs polymeric nanocapsules: The influence of the cationic lipid coating on the "4S".
C. Carbone (2016)
Semantic Scholar Logo Some data provided by SemanticScholar